42 results on '"Goulden, N"'
Search Results
2. Characteristics and outcome of children and young adults with Early T-Precursor (ETP) ALL treated on UKALL 2003: 18
3. Presence of mutations in the NOTCH1 signalling pathway has a beneficial impact on outcome in paediatric T-ALL patients treated on the MRC UKALL2003 trial: 42
4. FLT3-ITD mutations as a prognostic factor in children with AML - experience in a uniformly treated, large, single centre cohort: 117
5. Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003: 114
6. Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood lymphoblastic leukaemia (ALL): 4
7. Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T-cell-depleted bone marrow transplant recipients
8. Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation
9. Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL
10. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission
11. Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia
12. Down Syndrome is a significant risk factor for infectious deaths in childhood acute lymphoblastic leukaemia: a retrospective analysis of the infectious deaths on UKALL 2003
13. Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T-cell-depleted bone marrow transplant recipients.
14. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.
15. Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003.
16. Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
17. Central nervous system aspergillosis resembling haemorrhagic brain infarct in a paediatric leukaemia patient.
18. Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes.
19. Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
20. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
21. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
22. Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
23. The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemia.
24. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
25. Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.
26. Alpha interferon augments the graft-versus-leukaemia effect of second stem cell transplants and donor lymphocyte infusions in high-risk paediatric leukaemias.
27. Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation.
28. Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.
29. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
30. Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?
31. Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities.
32. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
33. Haploidentical stem cell transplantation for children with acute leukaemia.
34. Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.
35. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
36. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.
37. Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.
38. Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid.
39. Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia.
40. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.
41. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia.
42. Virus-associated haemophagocytic syndrome: further evidence for a T-cell mediated disorder.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.